ClinicalTrials.gg
Drug

Felzartamab clinical trials

Also written MOR202 and MOR03087.

studies test it
17
open now
6
in phase 3
4
first study started
2011

How each study uses felzartamab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the felzartamab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Felzartamab
12
MOR202, MOR03087, TJ202, HIB202, BIIB148
2

Development codes

MOR202
10
MOR03087
7
TJ202
6
BIIB148
6
HIB202
3

Studies by the year they started

17 studies that test it; most in 2021 (5)

Studies that test felzartamab, by start year
YearStudies
20111
20193
20215
20231
20241
20251
20265

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
11
Phase 3
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 15 · Other 2

Biogen (7) · HI-Bio, A Biogen Company (4) · TJ Biopharma Co., Ltd. (3) · Mario Negri Institute for Pharmacological Research (1) · Farsad Eskandary (1) · MorphoSys AG (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 2 in phase 3

Studies that test felzartamab, phase 3 first.

Studies

Open first, then newest update. How each study uses felzartamab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 17

Given beside what is tested · 1 — felzartamab is usual care or a partner of the new treatment

Codes

What other systems call felzartamab · ClinicalTrials.gg INT001384

  • MeSH (NLM) C000709267felzartamabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 3O9FA4XC02FELZARTAMABConfirmed FDA, NLM
  • NCI Thesaurus C97954FelzartamabOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.